Maja Okuka Email

Clinical Trials Regulatory and Compliance Coordinator . Regenerative Processing Plant

Current Roles

Employees:
11
Revenue:
$1.7M
About
Transforming Wellness Medicine Through Disruptive Natural Regenerative Medicine Based Products. We offer a wide range of innovative high quality soft tissue and wound care products for tissue regeneration. The science of regenerative healing is the pathway to Regenerative Processing Plant’s (RPP) FIRST STERILE PRODUCT of its kind on the market. Following years of studying and researching biologic birth tissues, RPP believes it has seized the power of the body’s natural healing in its Proprietary Cryo-Activ™ process in its initial disruptive product: PDA –Human Amniotic Fluid Cryo-Activ®. The Company has developed this process for sterilizing human amniotic fluid and has patents on this proprietary procedure which is a differentiated characteristic of the PDA-Human Amniotic Fluid Cryo-Activ®. While other products claim sterility, most are simply processed aseptically utilizing sterile techniques.RPP has a proprietary AmnioCleanse™ process used to Sterilize the product without losing Biological Activities.
Regenerative Processing Plant Address
34176 US Highway 19 N
Palm Harbor, FL
United States
Regenerative Processing Plant Email
Regenerative Processing Plant Phone Numbers
800-781-0818

Past Companies

Regenerative Processing Plant, LLCClinical Trials Regulatory and Compliance Coordinator
University of South FloridaSr. Biological Scientist/ Lab manager
Washington University in St. LouisLead Research Tech II